CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL.
Clinical trial NCT03671460 · UNKNOWN
Trial details
- NCT number
- NCT03671460
- Sponsor
- Tianjin Mycure Medical Technology Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-07
- Primary completion
- 2020-01-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.